Skip to main navigation menu Skip to main content Skip to site footer

Coexistence of May Thurner syndrome and paroxysmal nocturnal hemoglobinuria: a case report

Coexistencia de síndrome de May-Thurner y hemoglobinuria paroxística nocturna: a propósito de un caso



Open | Download

How to Cite

1.
Montoya Castillo M, Lahmann Herrera V. Coexistence of May Thurner syndrome and paroxysmal nocturnal hemoglobinuria: a case report. Rev. colomb. hematol. oncol. [Internet]. 2025 Jun. 27 [cited 2025 Dec. 5];12(1):155-62. https://doi.org/10.51643/22562915.739

Download Citation

Citations


Section
Clinic cases

How to Cite
1.
Montoya Castillo M, Lahmann Herrera V. Coexistence of May Thurner syndrome and paroxysmal nocturnal hemoglobinuria: a case report. Rev. colomb. hematol. oncol. [Internet]. 2025 Jun. 27 [cited 2025 Dec. 5];12(1):155-62. https://doi.org/10.51643/22562915.739

Dimensions
PlumX

Mariana Montoya Castillo,

Epidemióloga, Residente de Medicina Interna.


Valentina Lahmann Herrera,

Estudiante de Medicina.


Introduction: Deep vein thrombosis (DVT) causes high morbidity and mortality in young patients. Among the causes, May Thurner syndrome, an anatomical malformation that compresses the left iliac vein, and paroxysmal nocturnal hemoglobinuria (PNH), a rare hematologic disease associated with thrombosis and cytopenias, may explain cases of DVT. Clinical case: A 22-year-old female patient consulted for pain and edema of the left lower limb. Extensive DVT and an image suggestive of May Thurner syndrome was documented. Thrombectomy and stent implantation were performed, with favorable initial evolution. During follow-up, she presented thrombotic recurrence, hemolytic anemia and thrombocytopenia. Studies ruled out hereditary thrombophilia and confirmed PNH by flow cytometry. Eculizumab was started with clinical improvement. Discussion: The coexistence of May Thurner syndrome and PNH has not been previously reported. Both conditions predispose to thrombotic events, but with different pathophysiological mechanisms. Conclusion: This case highlights the importance of broadening the etiologic workup for unprovoked thrombotic events, especially in young patients with abnormal hematologic findings. Identification and specific treatment, such as the use of eculizumab in PNH, are key to improve prognosis.


Article visits 162 | PDF visits 107


Downloads

Download data is not yet available.
  1. Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, Fallarino A, Corso C, Valeriani E, Menichelli D, et al. A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology. International Journal of Molecular Sciences [Internet]. 2023;24(4):3169. Disponible en: https://doi.org/10.3390/ijms24043169 DOI: https://doi.org/10.3390/ijms24043169
  2. Colucci G, Tsakiris DA. Thrombophilia screening revisited: an issue of personalized medicine. J Thromb Thrombolysis [Internet]. 2020 May;49(4):618-629. Disponible en: https://doi.org/10.1007/s11239-020-02090-y DOI: https://doi.org/10.1007/s11239-020-02090-y
  3. Muñoz Rodríguez FJ. Diagnosis of deep vein thrombosis. Rev Clin Esp [Internet]. 2020 Jun 27:S0014-2565(20)30132-6. Disponible en: https://doi.org/10.1016/j.rce.2020.03.009 DOI: https://doi.org/10.1016/j.rce.2020.03.009
  4. Connors JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med [Internet]. 2017 Sep 21;377(12):1177-87. Disponible en: https://doi.org/10.1056/NEJMra1700365 DOI: https://doi.org/10.1056/NEJMra1700365
  5. Moran J, Bauer KA. Managing thromboembolic risk in patients with hereditary and acquired thrombophilias. Blood [Internet]. 2020 30;135(5):344-350. Disponible en: https://doi.org/10.1182/blood.2019000917. DOI: https://doi.org/10.1182/blood.2019000917
  6. Poyyamoli S, Mehta P, Cherian M, Anand RR, Patil SB, Kalva S, et al. May-Thurner syndrome. Cardiovasc Diagn Ther [Internet]. 2021;11(5):1104-1111. Disponible en: https//doi.org/10.21037/cdt.2020.03.07 DOI: https://doi.org/10.21037/cdt.2020.03.07
  7. Fazel R, Froehlich JB, Williams DM, Saint S, Nallamothu BK. Clinical problem-solving. A sinister development--a 35-year-old woman presented to the emergency department with a 2-day history of progressive swelling and pain in her left leg, without antecedent trauma. N Engl J Med [Internet]. 2007;357(1):53-9. Disponible en: https//doi.org/10.1056/NEJMcps061337 DOI: https://doi.org/10.1056/NEJMcps061337
  8. Saldarriaga, E., Vinasco, M., Jaimes, D. Síndrome de May-Thurner como diagnóstico diferencial en trombosis a repetición. Acta Med Colomb [Internet]. 2016;41(1):67-70. Disponible en: https://doi.org/10.36104/amc.2016.580 DOI: https://doi.org/10.36104/amc.2016.580
  9. Milanés Roldán MT, Fernández Delgado N, Fundora Sarraff T, Jaime Facundo JC, Hernández Ramírez P. Hemoglobinuria paroxística nocturna: actualización / Paroxysmal nocturnal haemoglobinuria. Rev. Cuba Hematol Inmunol Hemoter [Internet]. 2003;19(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892003000100001
  10. Szlendak U, Budziszewska B, Spychalska J, Drozd-Sokołowska J, Patkowska E, Nowak J. Paroxysmal nocturnal hemoglobinuria: advances in the understanding of pathophysiology, diagnosis, and treatment. Pol Arch Intern Med [Internet]. 2022;132(6):16271. Disponible en: https://doi.org/10.20452/pamw.16271. DOI: https://doi.org/10.20452/pamw.16271
  11. Resúmenes X Congreso latinoamericano de Medicina Interna XXVI Congreso ACMI-ACP. Hematología. Acta Médica Colombiana [Internet]. 2017,42(2):67-76. Disponible en https://www.redalyc.org/articulo.oa?id=163152399010 DOI: https://doi.org/10.36104/amc.2017.1148
  12. Shah N, Bhatt H. Paroxysmal Nocturnal Hemoglobinuria. [Updated 2023 Jul 31]. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK562292/
  13. Villegas A, Arrizabalaga B, Bonanad S, Colado E, Gaya A, González A, et al. Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica [Internet]. 2016;146(6):278.e1-278.e7. Disponible en https://doi.org/10.1016/j.medcli.2015.12.012 DOI: https://doi.org/10.1016/j.medcli.2015.12.012
  14. Cançado RD, Araújo A da S, Sandes AF, Arrais C, Lobo CL de C, Figueiredo MS, et al. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematology, Transfusion and Cell Therapy [Internet]. 2021;43(3):341-8. Disponible en: https://doi.org/10.1016/j.htct.2020.06.006 DOI: https://doi.org/10.1016/j.htct.2020.06.006
  15. Kim JS, Jang JH, Jo DY, Ahn SY, Yoon SS, Lee JH, et al. Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea. J Korean Med Sci [Internet]. 2023;38(41):e328. Disponible en: https://doi.org/10.3346/jkms.2023.38.e328 DOI: https://doi.org/10.3346/jkms.2023.38.e328
Sistema OJS 3.4.0.7 - Metabiblioteca |